Endocrine Abstracts

Congenital adrenal hyperplasia (CAH) is a genetic endocrine disorder associated with long-term health risks. Supported by the Society for Endocrinology, the original CaHASE study consisted of an initial questionnaire to UK centres providing specialist care to adults with CAH, followed by a nationwide audit. Three hundred and seventy-three patients from 17 centres were contacted between 2004 and 2007, 203 of whom agreed to participate (138 women, 65 men, median age 34 (range 18...

Congenital adrenal hyperplasia (CAH) is one of the commonest forms of primary adrenal insufficiency with an incidence of about 1 in 15,000. Over 10 years ago, several studies highlighted the suboptimal health status and care provision in adults with CAH that were associated with significant co-morbidities in relatively young adults. The Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) supported by the Society for Endocrinology was formed in 2003 to study the healt...

Following the roll-out of the I-DSD Registry in the 2000s, there was a consensus view that there was a need for a registry for congenital adrenal hyperplasia (CAH) and this was launched in 2014 as a dedicated module within the original registry. There are approximately 150 centres from 50 countries that are currently using the I-DSD/I-CAH/I-TS family of registries and between them there are almost 3,000 cases of CAH that have now been entered. In addition to supporting and pro...

Abstract Unavailable...